Claims for Patent: 10,894,042

✉ Email this page to a colleague

Summary for Patent: 10,894,042

Title:	Methods and pharmaceutical compositions for the treatment of cancer
Abstract:	The present invention relates to methods and pharmaceutical compositions for the treatment of cancer. More particularly, the present invention relates to a method of treating cancer in subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one OX1R antagonist.
Inventor(s):	Couvineau Alain, Gratio Valérie, Nicole Pascal, Voisin Thierry
Assignee:
Application Number:	US15525771
Patent Claims:

Details for Patent 10,894,042

Glossary

Show entries

Subscribe to access the full database, or Try for Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate

Genentech, Inc.	RITUXAN	rituximab	Injection	103705	November 26, 1997	10,894,042	2035-11-10
Idec Pharmaceuticals Corp.	RITUXAN	rituximab	Injection	103737	February 19, 2002	10,894,042	2035-11-10
Genzyme Corporation	CAMPATH	alemtuzumab	Injection	103948	May 07, 2001	10,894,042	2035-11-10
Genzyme Corporation	LEMTRADA	alemtuzumab	Injection	103948	November 14, 2014	10,894,042	2035-11-10
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.